Blueprint Medicines Income from Continuous Operations 2014-2025 | BPMC
Blueprint Medicines income from continuous operations for the twelve months ending March 31, 2025 was $-0.156B, a 45.98% decline year-over-year.
- Blueprint Medicines annual income from continuous operations for 2024 was $-0.067B, a 86.77% decline from 2023.
- Blueprint Medicines annual income from continuous operations for 2023 was $-0.507B, a 9.06% decline from 2022.
- Blueprint Medicines annual income from continuous operations for 2022 was $-0.558B, a 13.44% decline from 2021.